Volume 33, Issue 10 pp. 719-721

Granuloma caused by subcutaneous injection of leuprorelin acetate product: Case report and histopathological findings

Takeshi OUCHI

Takeshi OUCHI

Department of Dermatology, The Shizuoka Municipal Shimizu Hospital, Shimizu, Shizuoka, Japan

Search for more papers by this author
Tetushi KOYAMA

Tetushi KOYAMA

Department of Dermatology, The Shizuoka Municipal Shimizu Hospital, Shimizu, Shizuoka, Japan

Search for more papers by this author
Naho MIYATA

Naho MIYATA

Department of Dermatology, The Shizuoka Municipal Shimizu Hospital, Shimizu, Shizuoka, Japan

Search for more papers by this author
Makoto SUGIURA

Makoto SUGIURA

Department of Dermatology, The Shizuoka Municipal Shimizu Hospital, Shimizu, Shizuoka, Japan

Search for more papers by this author
First published: 16 October 2006
Citations: 12
Takeshi Ouchi, Shizuokashi Shimizuku Miyakami 1231, Shizuoka, Japan. Email: [email protected]

ABSTRACT

Leuprorelin acetate is a luteinizing hormone-releasing hormone (LH-RH) analog, which is used for chemical castration. Chemical castration treatment has an especially important role for prostate cancer. To ensure ongoing chemical castration, a novel sustained-action injection system using spherical microcapsules has been developed. We report a patient who had granuloma caused by administration of the 11.25 mg leuprorelin acetate product. Histological examination revealed many giant cells with vacuoles. On the basis of reported cases, these vacuoles are characteristic for the granuloma caused by leuprorelin acetate product. The vacuoles in the granuloma are the same size as the microcapsules, and their shape is almost spherical. We assume that the vacuoles in the granuloma are actually the microcapsules. We expect that there will be investigations regarding the procatarctic cause of granuloma formation.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.